In the wake of a Federal Trade Commission investigation into hospital group Renown Health, following a law firm’s own review of the group’s buyout of a cardiology practice, the Nevada-based business’s CEO and three other executives have resigned. Renown CEO Jim Miller has stepped down from his position after agreeing with the FTC to release 10 cardiologists from the practice the company acquired from non-compete agreements. The group additionally paid $4.2 million to a dozen cardiologists. Renown has acknowledged the antitrust probe as the reason for the CEO’s resignation; a press release from the group’s board chairman noted that “things did not go as planned” concerning the acquisition. He added, “If the execution of the SNCA transaction had been as solid as our intentions, none of this would have occurred.” SCNA, or Sierra Nevada Cardiology Associates, was acquired by Renown in March 2011.
Featured News
As Congress Considers a Ban On State AI Regs, California and NY Forge Ahead
Jun 19, 2025 by
CPI
Canada Watchdog Calls for Easing Foreign Investment Rules in Airline Sector
Jun 19, 2025 by
CPI
Litigation Finance Battle Heats Up in Tyson Foods Price-Fixing Case
Jun 19, 2025 by
CPI
Spain Weighs Additional Conditions on BBVA’s Hostile Bid for Sabadell
Jun 19, 2025 by
CPI
Japan’s TDK Buys SoftEye to Strengthen Smart Glasses Capabilities
Jun 19, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Theories of Harm
Jun 17, 2025 by
CPI
What Do We Mean by Harm to the Competitive Process?
Jun 17, 2025 by
Sean Sullivan
Is There a Better Approach to Vertical Merger Analysis?
Jun 17, 2025 by
Bob Majure & Andrew Sfekas
California’s Ill-Advised Turn Toward Europeanized Theories of Harm For Single-Firm Conduct
Jun 17, 2025 by
Geoffrey Manne, Dirk Auer & Brian Albrecht
EU Competition Policy in Support of Democracy and Sustainability: What Theories of Harm When Moving Away From the Predominance of the Consumer Welfare Paradigm?
Jun 17, 2025 by
Marios C. Iacovides